FDA Approves New First Treatment for Aggressive Breast Cancer

Women with triple-negative breast cancer just gained two powerful new treatment options that work better than standard chemotherapy at keeping the disease under control.

The FDA approved Trodelvy alone and combined with immunotherapy as first-line treatments for this aggressive cancer type.